ARCHIVES

US Oncology Begins Trial Of Taxotere And Xeloda

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

November 1, 1985

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997

Calif. Stem Cell Group To Collaborate With Canadians.

June 20, 2008

Benefit Of Chemotherapy Depends ER Status

April 28, 2006

Groups Have No Budgets As NCTN Begins Work March 1

February 28, 2014

Gleevec Improves Survival Of CML In Accelerated Phase

December 27, 2002